[HTML][HTML] Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous …

K Raja, M Patrick, JT Elder, LC Tsoi - Scientific reports, 2017 - nature.com
Adverse drug reactions (ADRs) pose critical public health issues, affecting over 6% of
hospitalized patients. While knowledge of potential drug-drug interactions (DDI) is …

Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases

K Raja, M Patrick, JT Elder, LC Tsoi - Scientific reports, 2017 - pubmed.ncbi.nlm.nih.gov
Adverse drug reactions (ADRs) pose critical public health issues, affecting over 6% of
hospitalized patients. While knowledge of potential drug-drug interactions (DDI) is …

Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases.

K Raja, M Patrick, JT Elder, LC Tsoi - Scientific Reports, 2017 - europepmc.org
Adverse drug reactions (ADRs) pose critical public health issues, affecting over 6% of
hospitalized patients. While knowledge of potential drug-drug interactions (DDI) is …

Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases

K Raja, M Patrick, JT Elder, LC Tsoi - Scientific Reports, 2017 - ui.adsabs.harvard.edu
Adverse drug reactions (ADRs) pose critical public health issues, affecting over 6% of
hospitalized patients. While knowledge of potential drug-drug interactions (DDI) is …

[HTML][HTML] Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous …

K Raja, M Patrick, JT Elder, LC Tsoi - Scientific Reports, 2017 - ncbi.nlm.nih.gov
Adverse drug reactions (ADRs) pose critical public health issues, affecting over 6% of
hospitalized patients. While knowledge of potential drug-drug interactions (DDI) is …